Private Equity: Trends and Outlook for 2023
Alpha Sense BI
DECEMBER 1, 2022
Challenging market conditions have not majorly affected interest in the biopharma space, with brisk investment in accelerating R&D and addressing supply chain issues through nearshoring and offshoring capital deployment. . CPG & Retail. A dislocated market lends opportunities for keen PE firms , however.
Let's personalize your content